Target intelligence / Profile preview

Protein phosphatase 1 regulatory subunit 3D (PPP1R3D)

Target
PPP1R3D
Molecular classification
Enzyme regulatory subunit, Protein phosphatase regulatory protein, Glycogen-targeting subunit
01

Overview

Protein phosphatase 1 regulatory subunit 3D (PPP1R3D) is a regulatory protein that acts as a glycogen-targeting subunit for protein phosphatase 1 (PP1), one of the major serine/threonine-specific protein phosphatases in eukaryotic cells[2][3][4][5]. PPP1R3D recruits PP1 to glycogen particles and modulates its substrate specificity, facilitating dephosphorylation of enzymes critical for glycogen synthesis and breakdown, such as glycogen synthase (GS) and glycogen phosphorylase (GP)[2][4]. It contains a conserved RVXF motif for PP1 binding, a separate motif for interacting with glycogenic substrates, and another binding site for 14-3-3 proteins, which regulate its stability and activity[2][4][6]. PPP1R3D plays important roles in glycogen homeostasis, cell division, protein synthesis, and muscle contractility[3][5]. Mutations or dysfunction of PPP1R3D have been linked to certain forms of epilepsy and may contribute to metabolic or neurological disease[3]. No drugs currently target PPP1R3D directly, and its modulation primarily influences PP1 activity and glycogen metabolism.

Other names
PPP1R3DPPP1R6PP1 subunit R6Protein phosphatase 1 regulatory subunit 6Protein phosphatase 1-binding subunit R6Spinophilin
02

Mechanism of action

Drugs targeting PP1 or related pathways (such as kinase/phosphatase modulators) would indirectly impact PPP1R3D function by altering PP1 recruitment or activity, but no known drugs directly target PPP1R3D

03

Biological functions

Regulation of glycogen metabolismModulation of protein phosphatase 1 substrate specificityRecruitment of PP1 to glycogen particlesCell divisionRegulation of muscle contractilityRegulation of protein synthesis
04

Disease associations

Progressive myoclonus epilepsyMyoclonic epilepsy of LaforaOther metabolic and neurological disorders (via general role in glycogen metabolism and cellular signaling)
05

Safety considerations

No direct safety concerns documented for therapeutics acting on PPP1R3D; theoretical concerns could involve dysregulation of glycogen metabolism or broad phosphatase activity if modulated

Beyond the preview

Go deeper on Protein phosphatase 1 regulatory subunit 3D (PPP1R3D).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein phosphatase 1 regulatory subunit 3D (PPP1R3D).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call